[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bioreactors-Europe Market Status and Trend Report 2013-2023

May 2018 | 135 pages | ID: B66F561C4208EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Bioreactors-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Bioreactors industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of Bioreactors 2013-2017, and development forecast 2018-2023
Main market players of Bioreactors in Europe, with company and product introduction, position in the Bioreactors market
Market status and development trend of Bioreactors by types and applications
Cost and profit status of Bioreactors, and marketing status
Market growth drivers and challenges

The report segments the Europe Bioreactors market as:

Europe Bioreactors Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe Bioreactors Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Single-use Bioreactors
Multiple-use Bioreactors

Europe Bioreactors Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food Industry
Pharmaceutical
Sewage Treatment
Biochemical Engineering
Others

Europe Bioreactors Market: Players Segment Analysis (Company and Product introduction, Bioreactors Sales Volume, Revenue, Price and Gross Margin):
Applikon Biotechnology
Pall Corporation
GE Healthcare
Sartorius AG
Eppendorf
Thermo Fisher Scientific
Cellexus
Celltainer Biotech BV
Finesse Solutions
Merck Millipore
PBS Biotech
Cellution Biotech
CerCell ApS
Electrolab Biotech
Infors AG
Pierre Guerin
Techniserv
Bioengineering AG
Broadley-Jamesn

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOREACTORS

1.1 Definition of Bioreactors in This Report
1.2 Commercial Types of Bioreactors
  1.2.1 Single-use Bioreactors
  1.2.2 Multiple-use Bioreactors
1.3 Downstream Application of Bioreactors
  1.3.1 Food Industry
  1.3.2 Pharmaceutical
  1.3.3 Sewage Treatment
  1.3.4 Biochemical Engineering
  1.3.5 Others
1.4 Development History of Bioreactors
1.5 Market Status and Trend of Bioreactors 2013-2023
  1.5.1 EMEA Bioreactors Market Status and Trend 2013-2023
  1.5.2 Regional Bioreactors Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Bioreactors in EMEA 2013-2017
2.2 Consumption Market of Bioreactors in EMEA by Regions
  2.2.1 Consumption Volume of Bioreactors in EMEA by Regions
  2.2.2 Revenue of Bioreactors in EMEA by Regions
2.3 Market Analysis of Bioreactors in EMEA by Regions
  2.3.1 Market Analysis of Bioreactors in Europe 2013-2017
  2.3.2 Market Analysis of Bioreactors in Middle East 2013-2017
  2.3.3 Market Analysis of Bioreactors in Africa 2013-2017
2.4 Market Development Forecast of Bioreactors in EMEA 2018-2023
  2.4.1 Market Development Forecast of Bioreactors in EMEA 2018-2023
  2.4.2 Market Development Forecast of Bioreactors by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of Bioreactors in EMEA by Types
  3.1.2 Revenue of Bioreactors in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Bioreactors in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Bioreactors in EMEA by Downstream Industry
4.2 Demand Volume of Bioreactors by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Bioreactors by Downstream Industry in Europe
  4.2.2 Demand Volume of Bioreactors by Downstream Industry in Middle East
  4.2.3 Demand Volume of Bioreactors by Downstream Industry in Africa
4.3 Market Forecast of Bioreactors in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOREACTORS

5.1 EMEA Economy Situation and Trend Overview
5.2 Bioreactors Downstream Industry Situation and Trend Overview

CHAPTER 6 BIOREACTORS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of Bioreactors in EMEA by Major Players
6.2 Revenue of Bioreactors in EMEA by Major Players
6.3 Basic Information of Bioreactors by Major Players
  6.3.1 Headquarters Location and Established Time of Bioreactors Major Players
  6.3.2 Employees and Revenue Level of Bioreactors Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 BIOREACTORS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Applikon Biotechnology
  7.1.1 Company profile
  7.1.2 Representative Bioreactors Product
  7.1.3 Bioreactors Sales, Revenue, Price and Gross Margin of Applikon Biotechnology
7.2 Pall Corporation
  7.2.1 Company profile
  7.2.2 Representative Bioreactors Product
  7.2.3 Bioreactors Sales, Revenue, Price and Gross Margin of Pall Corporation
7.3 GE Healthcare
  7.3.1 Company profile
  7.3.2 Representative Bioreactors Product
  7.3.3 Bioreactors Sales, Revenue, Price and Gross Margin of GE Healthcare
7.4 Sartorius AG
  7.4.1 Company profile
  7.4.2 Representative Bioreactors Product
  7.4.3 Bioreactors Sales, Revenue, Price and Gross Margin of Sartorius AG
7.5 Eppendorf
  7.5.1 Company profile
  7.5.2 Representative Bioreactors Product
  7.5.3 Bioreactors Sales, Revenue, Price and Gross Margin of Eppendorf
7.6 Thermo Fisher Scientific
  7.6.1 Company profile
  7.6.2 Representative Bioreactors Product
  7.6.3 Bioreactors Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.7 Cellexus
  7.7.1 Company profile
  7.7.2 Representative Bioreactors Product
  7.7.3 Bioreactors Sales, Revenue, Price and Gross Margin of Cellexus
7.8 Celltainer Biotech BV
  7.8.1 Company profile
  7.8.2 Representative Bioreactors Product
  7.8.3 Bioreactors Sales, Revenue, Price and Gross Margin of Celltainer Biotech BV
7.9 Finesse Solutions
  7.9.1 Company profile
  7.9.2 Representative Bioreactors Product
  7.9.3 Bioreactors Sales, Revenue, Price and Gross Margin of Finesse Solutions
7.10 Merck Millipore
  7.10.1 Company profile
  7.10.2 Representative Bioreactors Product
  7.10.3 Bioreactors Sales, Revenue, Price and Gross Margin of Merck Millipore
7.11 PBS Biotech
  7.11.1 Company profile
  7.11.2 Representative Bioreactors Product
  7.11.3 Bioreactors Sales, Revenue, Price and Gross Margin of PBS Biotech
7.12 Cellution Biotech
  7.12.1 Company profile
  7.12.2 Representative Bioreactors Product
  7.12.3 Bioreactors Sales, Revenue, Price and Gross Margin of Cellution Biotech
7.13 CerCell ApS
  7.13.1 Company profile
  7.13.2 Representative Bioreactors Product
  7.13.3 Bioreactors Sales, Revenue, Price and Gross Margin of CerCell ApS
7.14 Electrolab Biotech
  7.14.1 Company profile
  7.14.2 Representative Bioreactors Product
  7.14.3 Bioreactors Sales, Revenue, Price and Gross Margin of Electrolab Biotech
7.15 Infors AG
  7.15.1 Company profile
  7.15.2 Representative Bioreactors Product
  7.15.3 Bioreactors Sales, Revenue, Price and Gross Margin of Infors AG
7.16 Pierre Guerin
7.17 Techniserv
7.18 Bioengineering AG
7.19 Broadley-Jamesn

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOREACTORS

8.1 Industry Chain of Bioreactors
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOREACTORS

9.1 Cost Structure Analysis of Bioreactors
9.2 Raw Materials Cost Analysis of Bioreactors
9.3 Labor Cost Analysis of Bioreactors
9.4 Manufacturing Expenses Analysis of Bioreactors

CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOREACTORS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications